Key result
Dexamethasone suppressed ANF-mediated cGMP formation by vascular smooth muscle cells in a dose-dependent manner, an effect blocked by protein synthesis inhibitors and glucocorticoid antagonists.
Why the study?
Does dexamethasone suppress ANF-mediated cGMP formation in cultured rat vascular smooth muscle cells?
Does dexamethasone suppress ANF-mediated cGMP formation in cultured rat vascular smooth muscle cells?
Glucocorticoids suppress ANF-mediated cGMP formation in vascular smooth muscle cells, suggesting a potential mechanism for glucocorticoid-induced hypertension.
Answers are grounded in this paper and cite their sources.
No immediate clinical implications; leaves open a glucocorticoid-ANF mechanism in hypertension.
The effect of glucocorticoids on the atrial natriuretic factor (ANF)-mediated formation of cyclic guanosine monophosphate (cGMP) by intact vascular smooth muscle cells (VSMC) was studied in rats. Cultured VSMC were obtained from the renal arteries of 14-week-old Wistar rats by the explant method. Micromolar concentrations of dexamethasone, given as pretreatment for 48 hours, suppressed the ANF-mediated response. The dexamethasone-induced suppression was detectable at 6 hours and reached a maximum 24 hours after administration in a dose-dependent manner. Inhibitors of protein synthesis blocked this effect of the glucocorticoid. The basal activity of guanylate cyclase in the dexamethasone-treated cells was lower than in the control cells. Other steroids having glucocorticoid action mimicked this suppression of the ANF-mediated response. This suppression was blocked by a glucocorticoid receptor antagonist. The results suggest that glucocorticoids suppress ANF-mediated cGMP formation by VSMC through glucocorticoid type II receptors and the induction of protein synthesis. Suppression of the ANF-mediated response may play a role in glucocorticoid-induced hypertension.
No takes yet. Share an insight, caveat, or question.
Yasunari et al. (1990) studied this question. Dexamethasone vs. Control cells was evaluated on ANF-mediated formation of cyclic guanosine monophosphate (cGMP). Dexamethasone suppressed ANF-mediated cGMP formation by vascular smooth muscle cells in a dose-dependent manner, an effect blocked by protein synthesis inhibitors and glucocorticoid antagonists.
Synapse has enriched 10 related papers. Consider them for comparative context: